Compounds > camptothecin
Page last updated: 2024-08-22

camptothecin and Animal Mammary Carcinoma

camptothecin has been researched along with Animal Mammary Carcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, Y; Fang, J; Guo, X; Jin, Y; Liang, X; Lu, W; Sun, W; Tian, J; Yu, C; Zheng, J1
Borst, P; Greenberger, L; Jonkers, J; Rottenberg, S; Sol, W; van Tellingen, O; Zander, SA; Zhang, Y1
Anderson, K; Atkinson, J; Bandyopadhyay, A; Gilbert, BE; Kline, K; Knight, V; Lawson, KA; Sanders, BG; Simmons-Menchaca, M; Snyder, RM; Sun, LZ1
Bowen, JM; Gibson, RJ; Keefe, DM1
Kirichenko, AV; Rich, TA1

Other Studies

5 other study(ies) available for camptothecin and Animal Mammary Carcinoma

ArticleYear
Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer.
    Biomaterials, 2019, Volume: 217

    Topics: Animals; Camptothecin; Cell Line, Tumor; Combined Modality Therapy; Female; Fluorescence; Hyaluronic Acid; Hyperthermia, Induced; Immunity; Immunotherapy; Mammary Neoplasms, Animal; Mice; Nanoparticles; Neoplasm Metastasis; Neoplasm Recurrence, Local; Optical Imaging; Photoacoustic Techniques; Phototherapy; Polymers; Pyrroles; Tissue Distribution

2019
EZN-2208 (PEG-SN38) overcomes ABCG2-mediated topotecan resistance in BRCA1-deficient mouse mammary tumors.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Adenosine; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; BRCA1 Protein; Camptothecin; Diketopiperazines; DNA Topoisomerases, Type I; Female; Gene Expression; Heterocyclic Compounds, 4 or More Rings; Irinotecan; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Knockout; Mutation; Polyethylene Glycols; Survival Rate; Topoisomerase I Inhibitors; Topotecan

2012
Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
    Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:5

    Topics: Aerosols; alpha-Tocopherol; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Female; Lymphatic Metastasis; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Vitamin E

2004
Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats.
    International journal of cancer, 2005, Sep-01, Volume: 116, Issue:3

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Diarrhea; Female; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Irinotecan; Keratinocytes; Mammary Neoplasms, Animal; Rats; Survival Analysis

2005
Radiation enhancement by 9-aminocamptothecin: the effect of fractionation and timing of administration.
    International journal of radiation oncology, biology, physics, 1999, Jun-01, Volume: 44, Issue:3

    Topics: Animals; Antineoplastic Agents; Camptothecin; Circadian Rhythm; Combined Modality Therapy; Drug Administration Schedule; Female; Injections, Intramuscular; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Radiation-Sensitizing Agents; Specific Pathogen-Free Organisms

1999